Antibiotic resistant Streptococcus pneumoniae

Thorax

Volumn 51, Issue SUPPL. 2, 1996, Pages

  Minton, E J ^a   Macfarlane, J T ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; DRUG EFFECT; HUMAN; LOBAR PNEUMONIA; PENICILLIN RESISTANCE; PROSPECTIVE STUDY; REVIEW; STREPTOCOCCUS PNEUMONIAE;

CEPHALOSPORIN RESISTANCE; HUMANS; PENICILLIN RESISTANCE; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 0030207661     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.Suppl_2.S45     Document Type: Article

References (57)

1. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
2. Weingarten RD, Marckiewicz Z, Gilbert DN. Meningitis due to penicillin-resistant Streptococcus pneumoniae in adults. Rev Infect Dis 1990; 12:118-24.
3. Pallares R, Gudiol F, Linares J, Ariza J, Rufi G, Murgui L, et al. Risk factors and response to antibiotic therapy in adults with bacterial pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987;317:18-22.
4. Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
5. Macfarlane JT, Ward MJ, Finch RG, Macrae AD. Hospital study of adult community-acquired pneumonia. Lancet 1982; ii:255-8.
6. CDC. Pneumococcal vaccine usage, United States. MMWR 1984;33: 273-6.
7. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR. Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 1986;108:616-25.
8. Berman S, Mcintosh K. Selective primary health care: strategies for control of disease in the developing world. XXI. Acute respiratory infections. Rev Infect Dis 1985;7:674-91.
9. Finkelstein MS, Petkun WM, Freedman MK, Antopol SC. Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome. J Am Geriatr Soc 1983;31:19-27.
10. Garci-Leoni ME, Moreno S, Rodeno P, Cercenado E, Vincente T, Bouza E. Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus. Arch Intern Med 1992;152:1808-12.
11. Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection. Ann Intern Med 1992;117:314-24.
12. Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. BMJ 1985;290:505-8.
13. Mylotte JM, Beam TR. Comparison of community-acquired and nosocomial pneumococcal bacteremia. Am Rev Respir Dis 1981;123:265-8.
14. Baron EJ, Peterson LR, Finegold SM. Streptococci and related genera. In: Bailey & Scott's Diagnostic Microbiology. St Louis: Mosby 1994: 331-52.
15. Tilghman RC, Finland M. Clinical significance of bacteremia in pneumococcal pneumonia. Arch Intern Med 1937;59:602-19.
16. Austrian R. Confronting drug-resistant pneumococci. Ann Intern Med 1994;121:807-8.
17. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964;60: 759-76.
18. Hook EW, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 1983;249:1055-7.
19. Schmidt LH, Sesler CL. Development of resistance to penicillin by pneumococci. Proc Soc Exp Biol Med 1943;52:353-7.
20. Kislak JW, Razavi LM, Daly AK, Finland M. Susceptibility of pneumococci to nine antibiotics. Am J Med Sci 1965:261-8.
21. Hansman D, Bullen M. A resistant pneumococcus. Lancet. 1967;112: 264-5.
22. Hansman D, Glasgow H, Stun J, Devitt L, Douglas R. Increased resistance to penicillin of pneumococci isolated from man. N Engl J Med 1971;284:175-7.
23. Koornhof HJ, Wasas A, Klugman K. Antimicrobial resistance in Streptococcus pneumoniae: a South African perspective. Clin Infect Dis 1992; 15:84-94.
24. Linares J, Pallares R, Alonso T, Perez JL, Ayats J, Gudiol F, et al. Trends in antimicrobial resistance of clinica; isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992;15:99-105.
25. Marton A. Pneumococcal antimicrobial resistance: the problem in Hungary. Clin Infect Dis 1992;15:106-11.
26. Jacobs MR. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1992;15:119-27.
27. Handwerger S, Tomasz A. Alterations in kinetic properties of penicillin-binding proteins of penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1986;17:364-71.
28. Dowson CG, Hutchison A, Woodford N, Johnson AP, George RC, Spratt BG. Penicillin-resistant strains of viridans streptococci have obtained altered penicillin-binding proteins from penicillin resistant Streptococcus pneumoniae. Proc Natl Acad Sci USA 1990;87:8842-6.
29. Negri MC, Morosini MI, Loza E, Baquero F. In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrob Agents Chemother 1991;330:1247-51.
30. Coffey TJ, Dowson CG, Daniels M, Spratt B. Genetics and microbiology of β-lactam-resistant pneumococci. Microb Drug Resist 1995;1:29-34.
31. Dowson CG, Hutchison A, Brannigan JA, George RG, Hansman D, Linares J, et al. Horizontal transfer of penicillin-binding protein genes in penicillin resistant isolates of Streptococcus pneumoniae. Proc Natl Acad Sci USA 1989;86:8842-6.
32. Soares S, Kristinsson KG, Musser Jm, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168:15863.
33. Johnson AP, Speller DCE, Patel BC. Sensitivity to cefotaxime of pneumococci isolated in the UK. J Antimicrob Chemother 1995;35:443-4.
34. Hofmann J, Cetron MS, Farley MM, Baughman WS, Facklam RR, Elliott JA, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
35. Nava JM, Bella F, Garau J, Lite J, Morera M, Marti C, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994;19:884-90.
36. Lonks JR, Medeiros AA. The growing threat of antibiotic-resistant Streptococcus pneumoniae. Med Clin North Am 1995;79:523-35.
37. Hoge CW, Adams J, Buchanan B, Sears SD. Enterococcal bacteremia: to treat or not to treat, a reappraisal. Rev Infect Dis 1991;13:600-5.
38. Friedland IR, Klugman KP. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 1992;146:920-3.
39. Tan TQ, Mason EQ, Kaplan SL. Systemic infections due to Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics 1992;90:928-33.
40. Feldman C, Kallenbach JM, Miller SD, Thorbun JR, Koornhof HJ. Community acquired pneumonia due to penicillin-resistant pneumococci. N Engl J Med 1985;313:615-7.
41. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331: 377-82.
42. Robbins JB, Austrian R, Lee CJ, Rastogi SG, Schiffman G, Henrichson J, et al. Considerations for formulating the second-generation pneumococcal capsular vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 1983;148:1136-59.
43. Centers for Disease Control. Recommendations of the Immunization Practices Advisory Committee: pneumococcal polysaccharide vaccine. MMWR 1989;38:64-8.
44. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococal polysaccharide vaccine efficacy. JAMA 1933;270: 1826-31.
45. Centers for Disease Control. Increasing pneumococcal vaccination rates among patients of a National Health-Care Alliance-United States, 1993. MMWR 1995;44:741-4.
46. Siber GR. Pneumococcal disease: prospects for a new generation of vaccines. Science 1994;265:1385-7.
47. Soyka LF, Robinson DS, Lanchant N, Monaco J. The misuse of antibiotics for treatment of upper respiratory tract infections in children. Pediatrics 1975;55:552-6.
48. Faryna A, Wergowske GL, Goldenberg K. Impact of therapeutic guidelines on antibiotic use by residents in primary care clinics. J Gen Intern Med 1987;2:102-7.
49. Davey PG, Bax RP, Newey J, Reeves D, Rutherford D, Slack R, et al. Growth in the use of antibiotics in the community in England and Scotland in 1980-3. BMJ 1996;312:613.
50. Macfarlane JT, Holmes WF, Macfarlane RM. Factors affecting a general practitioner's (GP) decision to prescribe an antibiotic for acute chest symptoms, icluding cough, in adults. Thorax 1995;50(Suppl 2):A86.
51. Bates J, Jordens JZ, Griffiths DT. Harm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 1994;34:507-16.
52. Murray BE. Editorial response: what can we do about vancomycin-resistant enterococci? Clin Infect Dis 1995;20:1134-6.
53. Nissinen A, Leinonen M, Huovinen P, Herva E, Katila ML, Kontiainen S, et al. Antimicrobial resistance of Streptococcus pneumoniae in Finland, 1987-1990. Clin Infect Dis 1995;20:1275-80.
54. Verhaegen J, Glupczynski Y, Verbist L, Blogie M, Verbiest N, Vandeven J, et al. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-83. Clin Infect Dis 1995;20:1339-15.
55. Yshida R, Kaku M, Kohno S, Ishida K, Mizukane R, Takemura H, et al. Trends in antimicrobial resistance of Streptococcus pneumoniae in Japan. Antimicrob Agents Chemother 1995;39:1196-8.
56. Magnus T, Andersen BM. Serotypes and resistance patterns of Streptococcus pneumoniae causing systemic disease in northern Norway. Eur J Clin Microbiol Infect Dis 1995;14:229-34.
57. Kanavaki S, Karabela S, Marinis E, Legakis NJ. Antibiotic resistance of clinical isolates of Streptococcus pneumoniae in Greece. J Clin Microbiol 1994;32:3056-8.